title: FDA to tighten labeling on long acting opioids.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000009:adverse effects; D003692:Delayed-Action Preparations / Q000008:administration & dosage* / Q000009:adverse effects; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D005260:Female; D006801:Humans; D007880:Legislation, Drug / Q000639:trends; D008297:Male; D009293:Opioid-Related Disorders / Q000517:prevention & control*; D010146:Pain / Q000188:drug therapy*; D011358:Product Surveillance, Postmarketing; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
chemical_list: D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations